QuantumScape
QS
$8.66
+2.85%
QuantumScape Corporation is a development-stage company pioneering next-generation solid-state lithium-metal batteries for electric vehicles and other applications. It operates as a pre-revenue technology disruptor in the Auto - Parts industry, aiming to commercialize batteries with superior energy density, faster charging, and enhanced safety compared to conventional lithium-ion technology. The current investor narrative is intensely focused on the company's technical progress toward commercialization against a backdrop of persistent financial losses and cash burn, with recent stock volatility driven by quarterly earnings reports that highlight both operational milestones and the long, capital-intensive road ahead to production and profitability.…
QS
QuantumScape
$8.66
Related headlines
QS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QuantumScape's 12-month outlook, with a consensus price target around $11.26 and implied upside of +30.0% versus the current price.
Average Target
$11.26
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$7 - $11
Analyst target range
Analyst coverage for QuantumScape is limited, with only 2 analysts providing estimates, which is typical for a pre-commercialization company and contributes to high volatility and less efficient price discovery. The consensus leans neutral to bearish, as reflected in recent institutional ratings where firms like Goldman Sachs and UBS maintain 'Sell' ratings, while Morgan Stanley and Baird have 'Equal-Weight' or 'Neutral' stances; the average revenue estimate for the next period is $495M, but this is a forward-looking projection for a company with no current sales, highlighting the speculative nature of the targets. The wide range between the low revenue estimate of $225.9M and the high of $794.4M underscores the extreme uncertainty surrounding the timing and scale of the company's commercial launch; the recent rating actions, including a downgrade from Evercore ISI from 'Outperform' to 'In Line' in November 2025, signal a cooling of near-term optimism despite reported technical progress.
Bulls vs Bears: QS Investment Factors
The evidence currently tilts decisively bearish, grounded in the harsh reality of zero revenue, persistent nine-figure quarterly losses, and a catastrophic 85% one-year price decline. The bull case rests entirely on future potential—a speculative belief in technology disruption years from commercialization. The single most important tension in the investment debate is the race against time and capital: Can QuantumScape achieve meaningful commercial revenue (projected by analysts at $495M on average) before its substantial cash reserves, defended by a strong balance sheet, are exhausted by its relentless ~$100M quarterly burn rate? The resolution of this binary outcome will determine if the stock is a forgotten pre-revenue casualty or a legendary turnaround story.
Bullish
- Technical Bounce from Extreme Lows: The stock has rallied 16.91% over the past month from deeply oversold levels, trading 19% above its 52-week low of $3.77. This suggests potential capitulation and a speculative bottoming attempt, supported by elevated average volume of 15.8M shares.
- Strong Balance Sheet with Minimal Debt: The company has a robust current ratio of 15.95 and a negligible debt-to-equity ratio of 0.06, providing significant financial flexibility to fund its multi-year R&D roadmap without immediate solvency risk. This liquidity is critical for a pre-revenue company burning ~$100M per quarter.
- Analyst Revenue Projections Signal Potential: Despite zero current revenue, analyst consensus projects an average of $495M in future revenue, with a high estimate of $794.4M. This forward-looking optimism, albeit speculative, underpins the $6.0B market cap and suggests a belief in eventual commercialization.
- Valuation De-rating from Peak Levels: The price-to-book ratio has compressed from over 12.75 in 2021 to 5.13 currently, reflecting a significant de-rating of speculative excess. While still elevated, this lower multiple reduces some downside risk if technical milestones are met.
Bearish
- Pre-Revenue with No Path to Profitability: The company reported $0 revenue and a net loss of $100.1M in Q4 2025, with a trailing free cash flow burn of -$278.75M. With negative gross profit and no commercial sales, the investment is a pure bet on unproven future execution years away.
- Catastrophic Long-Term Price Decline: The stock is down 85.20% over the past year and 60.63% over six months, trading 62% below its 52-week high. This severe technical damage reflects eroding investor confidence in the commercialization timeline and highlights extreme fundamental risk.
- Extreme Volatility and Market Correlation Risk: With a beta of 2.556, QS is over 2.5x more volatile than the market. This magnifies downside during market corrections and makes the stock unsuitable for risk-averse investors, as evidenced by its 22% underperformance vs. the S&P 500 over the last 3 months.
- Heavy Cash Burn and Negative Returns: The company exhibits deeply negative profitability metrics: a Return on Equity of -37.22% and a forward PE of -11.75. Sustained quarterly losses of $100M-$120M necessitate future dilutive equity raises, threatening shareholder value.
QS Technical Analysis
The stock is in a pronounced long-term downtrend, as evidenced by a staggering 1-year price decline of 85.20%. Currently trading at $7.26, the price sits near the bottom of its 52-week range, approximately 19% above its 52-week low of $3.77 and 62% below its 52-week high of $19.07; this positioning deep in the lower quartile suggests the stock is deeply out of favor, presenting a potential value opportunity for speculative investors but also signaling significant fundamental and technical damage that may not be over. Recent momentum shows a stark divergence, with the stock posting a strong 1-month gain of 16.91% but remaining down 17.97% over the last 3 months; this short-term bounce from oversold lows, which occurred on elevated volume (average 15.8M shares), could indicate a potential relief rally or bottoming attempt, though it remains within the context of the severe longer-term downtrend. Key technical support is clearly defined at the 52-week low of $3.77, while resistance lies at the recent recovery high near $12-13 and the 52-week high of $19.07; a sustained breakout above the $12-13 zone would be necessary to signal a more meaningful trend reversal. The stock's extreme volatility is quantified by a beta of 2.556, meaning it is over 2.5 times more volatile than the broader market, which necessitates outsized risk tolerance and careful position sizing for any investor.
Beta
2.58
2.58x market volatility
Max Drawdown
-67.7%
Largest decline past year
52-Week Range
$4-$19
Price range past year
Annual Return
+100.9%
Cumulative gain past year
| Period | QS Return | S&P 500 |
|---|---|---|
| 1m | +34.5% | +8.2% |
| 3m | +11.5% | +9.0% |
| 6m | -35.5% | +10.5% |
| 1y | +100.9% | +26.5% |
| ytd | -21.7% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QS Fundamental Analysis
QuantumScape remains a pre-revenue company, with its most recent quarterly revenue reported as $0, a figure consistent across all provided income statements; the absence of commercial sales underscores its status as a development-stage entity, with the investment case entirely hinged on future commercialization success rather than current growth metrics. The company is deeply unprofitable, reporting a net loss of $100.1M for Q4 2025 and a trailing-twelve-month free cash flow of -$278.75M; gross profit is negative at -$15.39M for the quarter, indicating costs exceed any nominal revenue, and the trend shows net losses have persisted in the range of $100M to $120M per quarter, with no clear near-term path to profitability given the heavy R&D and capital expenditure requirements. The balance sheet shows a strong current ratio of 15.95, indicating ample short-term liquidity, and a very low debt-to-equity ratio of 0.06, suggesting minimal financial leverage risk; however, the persistent and substantial cash burn, evidenced by negative operating cash flow of -$56.15M in Q4 2025 and a negative Return on Equity of -37.22%, highlights a dependency on external equity financing to fund operations and its multi-year development roadmap.
Quarterly Revenue
$0.0B
2025-12
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-278750000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QS Overvalued?
Given the company's negative net income and negative EBITDA, the primary valuation metric is the Price-to-Sales (PS) ratio; however, with zero revenue, the PS ratio is 0, rendering traditional multiples meaningless and highlighting that the stock's $6.0B market cap is valued entirely on future potential, not current financials. In the absence of a meaningful sector PS comparison, valuation is purely speculative and based on discounted cash flow models of future battery sales; the forward PE ratio of -11.75, while negative, is less negative than the trailing PE of -13.79, suggesting analysts expect losses to narrow slightly in the coming year. Historically, the stock's valuation has collapsed from its peak, with its price-to-book ratio falling from over 12.75 in early 2021 to 5.13 currently; while this represents a significant de-rating, the PB ratio remains elevated for an asset-light R&D firm, indicating the market still ascribes substantial value to its intellectual property and future optionality, albeit at a fraction of prior optimism.
PE
-13.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -55x~167x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-16.3x
Enterprise Value Multiple
Investment Risk Disclosure
The paramount financial risk is the company's unsustainable cash burn rate, with a trailing free cash flow of -$278.75M and quarterly net losses consistently around $100M. With $0 revenue and negative gross profit, operations are entirely funded by the balance sheet, creating a dependency on future equity or debt raises that will dilute existing shareholders. The company's valuation of $6.0B is purely speculative, as traditional metrics like PS (0) and PE (-13.79) are meaningless, leaving the stock price unmoored from financial fundamentals and highly sensitive to sentiment shifts.
Market and competitive risks are severe. Trading at a Price-to-Book of 5.13, QS commands a premium valuation for an asset-light R&D firm, leaving it vulnerable to further de-rating if commercialization timelines slip. The beta of 2.556 indicates extreme volatility and high correlation to market risk-off moves, potentially triggering sharp sell-offs unrelated to company-specific news. Furthermore, the solid-state battery space is intensely competitive, with well-funded incumbents and startups also racing to market, threatening QS's first-mover advantage and future pricing power.
The worst-case scenario involves a 'failure to launch': persistent technical hurdles delay commercialization beyond the company's cash runway, leading to a dilutive emergency capital raise at a severely depressed valuation. Coupled with a broader market downturn compressing speculative tech multiples, this could trigger a re-test and break of the 52-week low of $3.77. From the current price of $7.26, this scenario implies a realistic downside of approximately -48%. A chain of a missed technical milestone, an analyst downgrade cycle, and accelerated cash burn could catalyze this decline, effectively valuing the company closer to its tangible book value rather than its future optionality.